J1072 HCPCS code: Injection, testosterone cypionate (azmiro), 1 mg
J1072 is the HCPCS Level II code for injection, testosterone cypionate (azmiro), 1 mg. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 400 per day on DME suppliers.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2025-04-01 |
| Last action effective | 2025-04-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 400 | Prescribing Information |
| outpatient hospital claims | 400 | Prescribing Information |
| practitioner claims | 400 | Prescribing Information |
Medicare policy articles for this code
- A58828: Billing and Coding: Treatment of Males with Low Testosterone (Palmetto GBA (MAC - Part A, MAC - Part B))
- A58828: Billing and Coding: Treatment of Males with Low Testosterone (Palmetto GBA (MAC - Part A, MAC - Part B))
Covered diagnoses (40 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D35.2 | Benign neoplasm of pituitary gland | 1 |
| D44.3 | Neoplasm of uncertain behavior of pituitary gland | 1 |
| E23.0 | Hypopituitarism | 1 |
| E23.1 | Drug-induced hypopituitarism | 1 |
| E23.3 | Hypothalamic dysfunction, not elsewhere classified | 1 |
| E23.6 | Other disorders of pituitary gland | 1 |
| E23.7 | Disorder of pituitary gland, unspecified | 1 |
| E29.1 | Testicular hypofunction | 1 |
| E29.8 | Other testicular dysfunction | 1 |
| E30.0 | Delayed puberty | 1 |
Showing 10 of 40. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J1072
- April 2025: Code appears in this HCPCS release
- 2025-04-01: J1072 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1072?
J1072 is the HCPCS Level II code for injection, testosterone cypionate (azmiro), 1 mg. Short descriptor: "Inj, testosterone, azmiro".
Does Medicare cover J1072?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Which diagnoses support coverage for J1072?
Medicare policy articles that cite J1072 list 40 covered ICD-10-CM diagnosis codes across 2 articles. The most cited include D35.2 (Benign neoplasm of pituitary gland), D44.3 (Neoplasm of uncertain behavior of pituitary gland), E23.0 (Hypopituitarism). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J1072 can be billed per day?
400 on DME suppliers; 400 on outpatient hospital claims; 400 on practitioner claims (NCCI medically unlikely edits).
Related J10 codes
- J1000 — Injection, depo-estradiol cypionate, up to 5 mg
- J1010 — Injection, methylprednisolone acetate, 1 mg
- J1020 — Injection, methylprednisolone acetate, 20 mg
- J1030 — Injection, methylprednisolone acetate, 40 mg
- J1040 — Injection, methylprednisolone acetate, 80 mg
- J1050 — Injection, medroxyprogesterone acetate, 1 mg
- J1060 — Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 — Injection, testosterone cypionate, up to 100 mg
- J1071 — Injection, testosterone cypionate, 1 mg
- J1080 — Injection, testosterone cypionate, 1 cc, 200 mg
- J1094 — Injection, dexamethasone acetate, 1 mg
- J1095 — Injection, dexamethasone 9 percent, intraocular, 1 microgram
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1072
- Watch J1072 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1072
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.